Cargando…
Development of Hepatic Steatosis After Chemotherapy for Non‐Hodgkin Lymphoma
Nonalcoholic fatty liver disease is the most common liver disorder in the developed world. Although typically reflecting caloric overload, it can also be secondary to drug toxicity. We aimed to describe the incidence and risk factors for de novo steatosis during chemotherapy for non‐Hodgkin lymphoma...
Autores principales: | Ben‐Yakov, Gil, Alao, Hawwa, Haydek, John P., Fryzek, Nancy, Cho, Min Ho, Hemmati, Mehdi, Samala, Vikram, Shovlin, Margaret, Dunleavy, Kieron, Wilson, Wyndham, Jones, Elizabeth C., Rotman, Yaron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357828/ https://www.ncbi.nlm.nih.gov/pubmed/30766960 http://dx.doi.org/10.1002/hep4.1304 |
Ejemplares similares
-
End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making
por: Melani, Christopher, et al.
Publicado: (2018) -
Harnessing Noxa demethylation to overcome Bortezomib resistance in mantle cell lymphoma
por: Leshchenko, Violetta V., et al.
Publicado: (2015) -
Chemotherapy-Colchicine Interaction in a Child with Familial Mediterranean Fever and Hodgkin Lymphoma
por: Langenberg-Ververgaert, Karin P.S., et al.
Publicado: (2018) -
Prognostic factors for adult patients with Burkitt lymphoma treated with dose-adjusted EPOCH-R
por: Lakhotia, Rahul, et al.
Publicado: (2023) -
Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphoma
por: Lakhotia, Rahul, et al.
Publicado: (2022)